ClinicalTrials.Veeva

Menu

A Randomized Trial of NSAID Dosing Strategies

Montefiore Medicine Academic Health System logo

Montefiore Medicine Academic Health System

Status and phase

Completed
Phase 4

Conditions

Musculoskeletal Pain
Acute Pain

Treatments

Drug: NSAID

Study type

Interventional

Funder types

Other

Identifiers

NCT05239767
2022-13802

Details and patient eligibility

About

This study will compare the efficacy of two different non-steroidal anti-inflammatory drugs (NSAIDs) ketorolac and ibuprofen for people with acute moderate or severe musculoskeletal pain. The investigators will also determine whether taking acetaminophen prior to the NSAID impacts efficacy

Enrollment

407 patients

Sex

All

Ages

18 to 69 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Acute musculoskeletal pain: Any pain attributable to muscles, bones, joints, tendons, ligaments or supporting structures, as determined by the clinical team, of 10 days duration or less. Prior to the onset of acute pain, patients cannot have experienced pain in the same body region during the prior six months
  • Pain has to be described as moderate or severe, when the patient is asked if the pain is mild, moderate or severe in intensity

Exclusion criteria

  • Contraindication to NSAIDs (allergy to NSAID or allergy to aspirin without history of tolerating NSAIDs, history of gastrointestinal bleeding, daily medication for gastritis or PUD, chronic kidney disease 2-5, heart failure)
  • Contraindication to acetaminophen (hepatitis or cirrhosis)
  • Use of an NSAID within the previous eight hours
  • Use of acetaminophen within the previous eight hours
  • Chronic pain, defined as any pain on >50% of days for at least 3 months prior to onset of acute pain
  • Recurrent pain in the same body part as the presenting complaint

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

Quadruple Blind

407 participants in 2 patient groups

Ketorolac
Active Comparator group
Description:
Ketorolac 20mg orally x 1
Treatment:
Drug: NSAID
Ibuprofen
Active Comparator group
Description:
Ibuprofen 800mg orally x 1
Treatment:
Drug: NSAID

Trial contacts and locations

1

Loading...

Central trial contact

Benjamin W Friedman, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems